Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

416 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ecological impact of isolated cognitive relapses in MS.
Meli R, Roccatagliata L, Capello E, Bruschi N, Uccelli A, Mancardi G, Inglese M, Pardini M. Meli R, et al. Among authors: mancardi g. Mult Scler. 2020 Jan;26(1):114-117. doi: 10.1177/1352458518813722. Epub 2018 Nov 15. Mult Scler. 2020. PMID: 30430928
Reward responsiveness and fatigue in multiple sclerosis.
Pardini M, Capello E, Krueger F, Mancardi G, Uccelli A. Pardini M, et al. Among authors: mancardi g. Mult Scler. 2013 Feb;19(2):233-40. doi: 10.1177/1352458512451509. Epub 2012 Jun 21. Mult Scler. 2013. PMID: 22723570
Isolated cognitive relapses in multiple sclerosis.
Pardini M, Uccelli A, Grafman J, Yaldizli Ö, Mancardi G, Roccatagliata L. Pardini M, et al. Among authors: mancardi g. J Neurol Neurosurg Psychiatry. 2014 Sep;85(9):1035-7. doi: 10.1136/jnnp-2013-307275. Epub 2014 Mar 31. J Neurol Neurosurg Psychiatry. 2014. PMID: 24686566
Cingulum bundle alterations underlie subjective fatigue in multiple sclerosis.
Pardini M, Bonzano L, Bergamino M, Bommarito G, Feraco P, Murugavel A, Bove M, Brichetto G, Uccelli A, Mancardi G, Roccatagliata L. Pardini M, et al. Among authors: mancardi g. Mult Scler. 2015 Apr;21(4):442-7. doi: 10.1177/1352458514546791. Epub 2014 Aug 21. Mult Scler. 2015. PMID: 25145692
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis.
Cellerino M, Boffa G, Lapucci C, Tazza F, Sbragia E, Mancuso E, Bruschi N, Minguzzi S, Ivaldi F, Poirè I, Laroni A, Mancardi G, Capello E, Uccelli A, Novi G, Inglese M. Cellerino M, et al. Among authors: mancardi g. Neurotherapeutics. 2021 Oct;18(4):2579-2588. doi: 10.1007/s13311-021-01104-8. Epub 2021 Sep 22. Neurotherapeutics. 2021. PMID: 34553320 Free PMC article.
416 results